epigenetics

Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts

Methylation profiling of cell-free DNA is opening new possibilities for detecting cancer at its earliest, pre-symptomatic stages, offering a potential breakthrough in how and when disease is found.

Multiomic approaches are advancing cancer research by delivering deeper insights and enabling more precise diagnostics and therapies.

New animal research suggests that the risk of developing cancer might be decided early in life.

Two mutations in the BRCA1 gene greatly increase the risk of breast cancer. Now, it seems that only one mutation can help cells tip toward a cancerous edge. ​

No pharmaceutical treatments exist for addictions to drugs like cocaine or cannabis. Now, scientists are engineering gene therapies, immunotherapies, and more.

Lifestyle and genetics intertwine to shape individual risk and the pathway to prediabetes reversal.

Explore the science behind young blood transfusion and blood rejuvenation therapy. Learn how researchers are studying the potential of young plasma to reverse the effects of aging.

Negative childhood experiences can leave epigenetic scars that haunt organisms for life.

A clearer look at chromatin structures in super resolution reveals new insights into cancer pathogenesis.